CLINICAL_TRIALS
research
· 2020-05-28
Clinical Trial Update: Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) [NA]
Summary
A completed prospective pilot study evaluating the use of Floseal for anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia (HHT), Epistaxis | NA | Status: COMPLETED | Results posted: 2020-05-28